Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 597Lung Neoplasms 187Neoplasms 66Neoplasm Metastasis 46Mesothelioma, Malignant 45Adenocarcinoma of Lung 42Mesothelioma 39Colorectal Neoplasms 29Carcinoma 23Breast Neoplasms 23Parkinson Disease 4, Autosomal Dominant Lewy Body 21Meningeal Carcinomatosis 19Head and Neck Neoplasms 19Brain Neoplasms 18Ovarian Neoplasms 17Adenocarcinoma 15Small Cell Lung Carcinoma 14NSCLC 14Pancreatic Neoplasms 12Melanoma 12Squamous Cell Carcinoma of Head and Neck 11Recurrence 11Lung Diseases 10Carcinoma, Transitional Cell 10Uterine Cervical Neoplasms 9Neoplasms by Site 9Adenocarcinoma, Bronchiolo-Alveolar 9Thoracic Neoplasms 8Non-squamous Non-small Cell Lung Cancer 8Carcinoma, Bronchogenic 8

Interventions

pembrolizumab 3Proton Therapy 2ribociclib 1palbociclib 1napabucasin 1fludarabine 1epacadostat 1bosutinib 1amrubicin 1alovudine 1Sunitinib 1Radiotherapy 1Radiosurgery 1Radiation 1Plicamycin 1Pemetrexed 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1FAPI-46 1Everolimus 1Erlotinib Hydrochloride 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Bevacizumab 1Albumin-Bound Paclitaxel 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thymus Neoplasms × Pemetrexed × Clear all
NCT03023319 2022-06-14

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Augusta University

Phase 1 Completed
6 enrolled
GenitourinaryGynecologicOther solid neoplasmThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Mesothelioma, Ovarian Neoplasms, Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡